What is the appropriate paracetamol dosage for a newborn weighing 2.5 kg?

Paracetamol Dosing for a 2.5 kg Newborn

For a newborn weighing 2.5 kg, the appropriate paracetamol dose depends on gestational age and route of administration, but generally ranges from 7.5-10 mg/kg per dose every 6-8 hours orally/rectally, or 7.5 mg (for preterm <32 weeks) to 12.5-15 mg (for term infants) intravenously every 6 hours.

Dosing by Route and Gestational Age

Oral/Rectal Administration

The dosing varies significantly based on gestational age 1:

• Preterm neonates at 30 weeks' gestation: 25-30 mg/kg/day divided into doses
• Preterm neonates at 34 weeks' gestation: 45 mg/kg/day divided into doses
• Term neonates (≥37 weeks): 60 mg/kg/day divided into doses

For a 2.5 kg infant, this translates to:

• 30 weeks GA: ~7.5 mg per dose every 8 hours (62.5-75 mg/day total)
• 34 weeks GA: ~11.25 mg per dose every 6 hours (112.5 mg/day total)
• Term infant: ~15 mg per dose every 6 hours (150 mg/day total)

Intravenous Administration

IV dosing is more precisely defined by gestational age 1:

• Preterm <32 weeks: Loading dose 12 mg/kg, then 6 mg/kg every 6 hours

  • For 2.5 kg: 30 mg loading, then 15 mg every 6 hours

• 32-44 weeks postmenstrual age: Loading dose 20 mg/kg, then 10 mg/kg every 6 hours 2

  • For 2.5 kg: 50 mg loading, then 25 mg every 6 hours

• Term neonates: Some sources suggest 20 mg/kg every 4 hours (propacetamol doses) 3

Critical Safety Considerations

Maximum daily doses must not be exceeded 4. The FDA labeling states consultation with a doctor is required for children under 2 years 4, reflecting the narrow therapeutic window in neonates.

Hepatotoxicity Risk

• Neonates have decreased protein binding and immature hepatic metabolism, particularly of the oxidative enzyme CYP2E1 3
• The role of the hepatotoxic metabolite N-acetyl-p-benzoquinone-imine production is unknown in premature neonates
• Never exceed recommended daily doses - severe liver damage can occur with overdosing 4

Dosing Pitfalls

1. Rectal absorption is erratic 5: Multiple rectal doses of 20 mg/kg led to widely varying serum concentrations and did not achieve therapeutic levels in all infants. Boys had significantly higher peak concentrations than girls (P=0.01).

2. Weight is the major covariate: Patient size (predicted by weight) accounts for 57.5% of clearance variance, while postmenstrual age contributes only 2.2% 6

3. Avoid underdosing in term infants: Standard label doses resulted in mean steady-state concentrations below therapeutic target (7.65 mg/L vs target 9-11 mg/L) 2

Practical Approach

For this 2.5 kg newborn, you must first determine:

1. Gestational age at birth
2. Current postmenstrual age (gestational age + postnatal age)
3. Route of administration available

Then apply the appropriate regimen:

• If preterm <32 weeks and IV available: 12 mg/kg loading (30 mg), then 6 mg/kg q6h (15 mg)
• If 32-44 weeks postmenstrual age and IV available: 20 mg/kg loading (50 mg), then 10 mg/kg q6h (25 mg)
• If oral/rectal only: Use gestational age-based daily dose divided appropriately, recognizing rectal absorption may be inadequate

Monitor closely as safety data remain limited in neonates, particularly extremely preterm infants 1. The mismatch between clinical use and evidence-based recommendations necessitates a cautious approach with continued surveillance.